Abstract:Background: Sepsis-induced myocardial dysfunction (SIMD) is the most common and severe sepsis-related organ dysfunction. We aimed to investigate the metabolic changes occurring in the hearts of patients suffering from SIMD. Methods: An animal SIMD model was constructed by injecting lipopolysaccharide (LPS) into mice intraperitoneally. Metabolites and transcripts present in the cardiac tissues of mice in the experimental and control groups were extracted, and the samples were studied following the untargeted metabolomics–transcriptomics high-throughput sequencing method. SIMD-related metabolites were screened following univariate and multi-dimensional analyses methods. Additionally, differential analysis of gene expression was performed using the DESeq package. Finally, metabolites and their associated transcripts were mapped to the relevant metabolic pathways after extracting transcripts corresponding to relevant enzymes. The process was conducted based on the metabolite information present in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Results: One hundred and eighteen significant differentially expressed metabolites (DEMs) (58 under the cationic mode and 60 under the anionic mode) were identified by studying the SIMD and control groups. Additionally, 3,081 significantly differentially expressed genes (DEGs) (1,364 were down-regulated and 1717 were up-regulated DEGs) were identified in the transcriptomes. The comparison was made between the two groups. The metabolomics–transcriptomics combination analysis of metabolites and their associated transcripts helped identify five metabolites ( d -mannose, d -glucosamine 6-phosphate, maltose, alpha-linolenic acid, and adenosine 5′-diphosphate). Moreover, irregular and unusual events were observed during the processes of mannose metabolism, amino sugar metabolism, starch metabolism, unsaturated fatty acid biosynthesis, platelet activation, and purine metabolism. The AMP-activated protein kinase (AMPK) signaling pathways were also accompanied by aberrant events. Conclusion: Severe metabolic disturbances occur in the cardiac tissues of model mice with SIMD. This can potentially help in developing the SIMD treatment methods.

Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach

A serum metabonomics study on drug induced liver injury by UPLC coupled with Q-TOF mass spectrometry

Identification of Serum Biomarker in Acute Aortic Dissection by Global and Targeted Metabolomics

Untargeted metabolic profiling reveals potential biomarkers in myocardial infarction and its application.

Metabolomics Study of the Biochemical Changes in the Plasma of Myocardial Infarction Patients

Serum Metabonomic Study of Patients with Acute Coronary Syndrome Using Ultra-Performance Liquid Chromatography Orbitrap Mass Spectrometer.

Plasma Metabolites–Based Prediction in Cardiac Surgery–Associated Acute Kidney Injury

Metabolic Dynamics in Critically Injured Patients: a Prospective Cohort Study Integrated with 1H NMR Metabolomics.

Urine metabolites imply metabolic rewiring of kidney and predict acute kidney injury after cardiac surgery

Landscape of Metabolic Fingerprinting for Diagnosis and Risk Stratification of Sepsis

Distinct Metabolic Profiles and Pathway Alterations in Myocardial Infarction and Unstable Angina Revealed by Metabolomics

Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application.

Metabolomic Profiling of Rat Serum Associated with Isoproterenol-Induced Myocardial Infarction Using Ultra-Performance Liquid Chromatography/Time-Of-Flight Mass Spectrometry and Multivariate Analysis

Serum metabolite profiling reveals metabolic characteristics of sepsis patients using LC/MS-based metabolic profiles: a cross-sectional study

Targeted metabolomic profiling of acute ST-segment elevation myocardial infarction

Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention

Metabolomics As a Critical Tool for Studying Clinical Surgery

Urine Metabolite Changes after Cardiac Surgery Predict Acute Kidney Injury.

Identification of Potential Plasma Biomarkers and Metabolic Dysfunction for Unstable Angina Pectoris and Its Complication Based on Global Metabolomics.

Serum metabolic signatures for acute pulmonary embolism identified by untargeted metabolomics

Analysis of metabolic disturbances attributable to sepsis-induced myocardial dysfunction using metabolomics and transcriptomics techniques